ENTITY
MicroPort Scientific

MicroPort Scientific (853 HK)

128
Analysis
Health Care • China
MicroPort Scientific is a leading global medical device company that innovates, manufactures, and markets high-end medical devices. The company provides solutions across twelve therapeutic areas, including cardiovascular, orthopedics, cardiac rhythm management, electrophysiology, endovascular, neurovascular, and surgical robotics. It was founded in 1998 and is headquartered in Shanghai, China.
more
bullish•MicroPort Scientific
•07 Aug 2026 18:56

Primer: MicroPort Scientific (853 HK) - Aug 2026

MicroPort Scientific is a diversified global medical device company with a strong presence in cardiovascular, orthopedics, and other...

Share
•19 Mar 2026 08:30

Zylox Tonbridge (2190 HK): 2025 Good; International Presence, Product Launches Will Shape the Future

​Zylox-Tonbridge Medical Technology (2190 HK) sees strong revenue growth driven by neurovascular and peripheral vascular devices. International...

Logo
223 Views
Share
•27 Apr 2021 07:29

Pre-IPO Zylox-Tonbridge Medical Technology - Promising Market with Challenges

This insights analyzed Zylox-Tonbridge Medical Technology in terms of the market potential, industry characteristics, business analysis, financial...

Logo
627 Views
Share
bullish•Astellas Pharma
•06 Sep 2025 01:08

Buys in Japan and Europe; China Pulling Back -- Buy; MSCI ACWI Uptrend Intact

Buys in Japan and Europe; China's Shanghai Composite Pulling Back to 10-year Base Support -- Buy; MSCI $ACWI Uptrend Intact. Actionable Themes:...

Logo
629 Views
Share
•24 Aug 2025 08:30

APAC Healthcare Weekly (Aug 24) – Wuxi Bio, Ab&B Bio, Ascletis Pharma, Remegen, Daiichi Sankyo, CSL

Wuxi Bio got EMA nod for Ireland manufacturing facility. Daiichi Sankyo got breakthrough therapy designation for its drug candidate in US. CSL...

Logo
698 Views
Share
x